Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-026385
Filing Date
2022-07-19
Accepted
2022-07-19 21:00:11
Documents
2
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1637
2 EX-24 DOCUMENT attachment1.htm EX-24 4038
  Complete submission text file 0000899243-22-026385.txt   7105
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Issuer) CIK: 0001403752 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 114 EAST 4TH AVENUE, SUITE 800 VANCOUVER A1 V5T 1G4
Business Address
Moore Paul Andrew (Reporting) CIK: 0001938192 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38068 | Film No.: 221092618